AbstractDa Vinci robot-assisted pancreaticoduodenectomy offers advantages, including minimal invasiveness, precise, and safe procedures. This study aimed to investigate the clinical effectiveness of implementing enhanced recovery after surgery (ERAS) concepts in Da Vinci robot-assisted pancreaticoduodenectomy.

达芬奇机器人辅助胰十二指肠切除术具有微创、精确、安全等优点。本研究旨在探讨达芬奇机器人辅助胰十二指肠切除术中实施增强术后恢复（ERAS）概念的临床有效性。

A retrospective analysis was conducted on clinical data from 62 patients who underwent Da Vinci robot-assisted pancreaticoduodenectomy between January 2018 and December 2022. Among these patients, 30 were managed with ERAS principles, while 32 were managed using traditional perioperative management protocols.

对2018年1月至2022年12月期间接受达芬奇机器人辅助胰十二指肠切除术的62例患者的临床数据进行了回顾性分析。在这些患者中，30例采用ERAS原则进行管理，32例采用传统的围手术期管理方案进行管理。

Surgical time, intraoperative blood loss, postoperative oral intake time, time to return of bowel function, time to ambulation, visual analog scale (VAS) pain scores, fluid replacement volume, length of hospital stay, total hospital expenses, complications, and patient satisfaction were recorded and compared between the two groups.

记录并比较两组患者的手术时间、术中出血量、术后口服时间、肠功能恢复时间、下床活动时间、视觉模拟评分（VAS）疼痛评分、补液量、住院时间、总住院费用、并发症和患者满意度。

Postoperative follow-up included assessment of postoperative functional scores, reoperation rates, SF-36 quality of life scores, and survival rates. The average follow-up time was 35.6 months (range: 12–56 months). There were no statistically significant differences in general characteristics, including age, surgical time, intraoperative blood loss, and preoperative medical history between the two groups (P > 0.05).

术后随访包括评估术后功能评分，再次手术率，SF-36生活质量评分和生存率。平均随访时间为35.6个月（范围：12-56个月）。两组患者的一般特征（包括年龄，手术时间，术中失血量和术前病史）无统计学差异（P>0.05）。

Compared to the control group, the intervention group had an earlier postoperative oral intake time, faster return of bowel function, rapid ambulation, and shorter hospital stays (P < 0.05). The intervention group also had lower postoperative VAS scores, lower fluid replacement volume, lower total hospital expenses, and a lower rate of complications (P < 0.05).

与对照组相比，干预组术后口服摄入时间较早，肠功能恢复较快，下床活动迅速，住院时间较短（P<0.05）。干预组术后VAS评分较低，补液量较低，总住院费用较低，并发症发生率较低（P<0.05）。

Patient satisfaction was higher in the intervention group (.

干预组患者满意度较高（。

IntroductionEnhanced recovery after surgery (ERAS), introduced by the ERAS Research Society in 2001, emerged from the early 1990s concepts of rapid postoperative recovery, also called fast-track surgery1. This approach was introduced by Kehlet H and colleagues from the University of Copenhagen in Denmark.

引言ERAS研究学会于2001年引入的增强术后恢复（ERAS）产生于20世纪90年代早期的术后快速恢复概念，也称为快速康复手术1。丹麦哥本哈根大学的Kehlet H及其同事介绍了这种方法。

They were among the initial contributors to the ERAS collaborative group and prominent researchers in the field of ERAS studies1,2,3. Recently, the ERAS concept has gained widespread application in gastrointestinal surgery.Pancreaticoduodenectomy is primarily employed for tumors located in the lower part of the bile duct, such as periampullary cancer, pancreatic head cancer, primary tumors of the duodenum, malignant tumors involving the pancreaticoduodenal area, gastrointestinal tumors, pancreatic and duodenal injuries, and the surgical treatment of rare diseases in the pancreatic head4,5.

他们是ERAS合作小组的最初贡献者之一，也是ERAS研究领域的杰出研究人员1,2,3。最近，ERAS概念在胃肠外科手术中得到了广泛应用。。

It is also used for the surgical management of chronic refractory pancreatitis. Pancreaticoduodenectomy is a complex surgery characterized by significant disruption of normal anatomical structures and relatively slow postoperative recovery, which significantly benefits from minimally invasive surgery and enhanced recovery6,7,8.

它也用于慢性难治性胰腺炎的手术治疗。胰十二指肠切除术是一种复杂的手术，其特征在于正常解剖结构的显着破坏和相对缓慢的术后恢复，这显着受益于微创手术和增强的恢复6,7,8。

Da Vinci Xi robot-assisted surgery facilitates precise identification of anatomical sites, accurate removal of lesions, and reduced damage to surrounding structures, thereby effectively minimizing surgical trauma9,10,11. Although ERAS protocols have been widely implemented in pancreaticoduodenectomy6,12,13, there have been no reports on applying ERAS protocols in Da Vinci robot-assisted pancreaticoduodenectomy.

达芬奇Xi机器人辅助手术有助于精确识别解剖部位，准确切除病变，减少对周围结构的损伤，从而有效减少手术创伤9,10,11。尽管ERAS协议已在胰十二指肠切除术中广泛实施[6,12,13]，但尚无关于在达芬奇机器人辅助胰十二指肠切除术中应用ERAS协议的报道。

Therefore, this study aimed to retrospectively analyze clinical data from patients who underwent Da Vinci robot-assisted pancreaticoduodenectomy and as.

。

Data availability

数据可用性

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

。

ReferencesLjungqvist, O., Scott, M. & Fearon, K. C. Enhanced recovery after surgery: A review. JAMA Surg. 152, 292–298 (2017).Article

参考文献Ljungqvist，O.，Scott，M。＆Fearon，K.C。手术后恢复增强：综述。《美国医学会杂志》152292-298（2017）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Su, S. et al. The Global States and hotspots of ERAS Research from 2000 to 2020: A bibliometric and visualized study. Front. Surg. 9, 811023 (2022).Article

Su，S.等人，《2000年至2020年ERAS研究的全球状态和热点：文献计量和可视化研究》。正面。Surg.9811023（2022）。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Li, C. et al. The pertinent literature of enhanced recovery after surgery programs: A bibliometric approach. Med. (Kaunas) 57, 172 (2021).

Li，C.等人。手术后恢复增强的相关文献：文献计量学方法。医学（考纳斯）57172（2021）。

Google Scholar

谷歌学者

Jiang, X. et al. Superior mesenteric artery first approach can improve the clinical outcomes of pancreaticoduodenectomy: A meta-analysis. Int. J. Surg. 73, 14–24 (2020).Article

Jiang，X。等。肠系膜上动脉第一入路可以改善胰十二指肠切除术的临床结果：荟萃分析。《国际外科杂志》73，14-24（2020）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Chen, Q. et al. Prognostic and recurrent significance of SII in patients with pancreatic head cancer undergoing pancreaticoduodenectomy. Front. Oncol. 13, 1122811 (2023).Article

Chen，Q。等。胰头癌胰十二指肠切除术患者SII的预后和复发意义。正面。Oncol公司。131122811（2023）。文章

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Xu, X., Zheng, C., Zhao, Y., Chen, W. & Huang, Y. Enhanced recovery after surgery for pancreaticoduodenectomy: Review of current evidence and trends. Int. J. Surg. 50, 79–86 (2018).Article

。《国际外科杂志》50,79-86（2018）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Wang, M. et al. Minimally invasive pancreaticoduodenectomy: A comprehensive review. Int. J. Surg. 35, 139–146 (2016).Article

Wang，M.等。微创胰十二指肠切除术：综合评论。《国际外科杂志》35139-146（2016）。文章

ADS

广告

PubMed

PubMed

Google Scholar

谷歌学者

Rosemurgy, A. et al. Cost analysis of pancreaticoduodenectomy at a high-volume robotic hepatopancreaticobiliary surgery program. J. Am. Coll. Surg. 232, 461–469 (2021).Article

Rosemurgy，A.等人，《大容量机器人肝胆胰外科手术中胰十二指肠切除术的成本分析》。J、 美国科罗拉多州。Surg.232461–469（2021）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Rosemurgy, A. et al. Robotic pancreaticoduodenectomy is the future: Here and now. J. Am. Coll. Surg. 228, 613–624 (2019).Article

Rosemurgy，A。等人。机器人胰十二指肠切除术是未来：现在和现在。J、 美国科罗拉多州。Surg.228613-624（2019）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Li, B. B. et al. Da Vinci robot-assisted pancreato-duodenectomy in a patient with situs inversus totalis: A case report and review of literature. World J. Gastrointest. Oncol. 14, 1363–1371 (2022).Article

Li，B.B.等人。达芬奇机器人辅助胰十二指肠切除术治疗总位反转患者：病例报告和文献复习。。Oncol公司。141363-1371（2022）。文章

ADS

广告

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Wang, R., Li, J., Tan, C. L., Liu, X. B. & Chen, Y. H. Prospects and applications of enucleation in solid pseudopapillary neoplasms of the pancreas. World J. Gastrointest. Oncol. 14, 1227–1238 (2022).Article

。。Oncol公司。141227-1238（2022）。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Melloul, E. et al. Guidelines for Perioperative Care for Pancreatoduodenectomy: enhanced recovery after surgery (ERAS) recommendations 2019. World J. Surg. 44, 2056–2084 (2020).Article

Melloul，E.等人，《胰十二指肠切除术围手术期护理指南：手术后恢复增强（ERAS）建议2019》。《世界外科杂志》442056-2084（2020）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Kuemmerli, C. et al. Impact of enhanced recovery protocols after pancreatoduodenectomy: Meta-analysis. Br. J. Surg. 109, 256–266 (2022).Article

。《英国外科杂志》109256-266（2022）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Bossi, P., De Luca, R., Ciani, O., D’angelo, E. & Caccialanza, R. Malnutrition management in oncology: An expert view on controversial issues and future perspectives. Front. Oncol. 12, 910770 (2022).Article

Bossi，P.，De Luca，R.，Ciani，O.，D'angelo，E.＆Caccialanza，R。肿瘤学中的营养不良管理：关于争议问题和未来前景的专家观点。正面。Oncol公司。12910770（2022年）。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Mantzavinou, A., Uppara, M., Chan, J. & Patel, B. Robotic versus open pancreaticoduodenectomy, comparing therapeutic indexes; a systematic review. Int. J. Surg. 101, 106633 (2022).Article

Mantzavinou，A.，Uppara，M.，Chan，J。＆Patel，B。机器人与开放式胰十二指肠切除术，比较治疗指标；系统评价。《国际外科杂志》101106633（2022）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Marino, M. V. et al. Robotic-assisted pancreaticoduodenectomy with vascular resection. Description of the surgical technique and analysis of early outcomes. Surg. Oncol. 35, 344–350 (2020).Article

Marino，M.V.等人。机器人辅助胰十二指肠切除术伴血管切除术。手术技术的描述和早期结果的分析。外科肿瘤学。35344-350（2020）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Cao, Y. et al. Impact of enhanced recovery after surgery on postoperative recovery for pancreaticoduodenectomy: Pooled analysis of observational study. Front. Oncol. 9, 687 (2019).Article

Cao，Y.等。术后恢复增强对胰十二指肠切除术后恢复的影响：观察性研究的汇总分析。正面。Oncol公司。9687（2019）。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Aarts, M. A. et al. Postoperative ERAS interventions have the greatest impact on optimal recovery: Experience with implementation of ERAS across multiple hospitals. Ann. Surg. 267, 992–997 (2018).Article

Aarts，M.A。等人。术后ERAS干预对最佳恢复的影响最大：在多家医院实施ERAS的经验。《安·外科杂志》267992-997（2018）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Lassen, K. et al. Pancreaticoduodenectomy: ERAS recommendations. Clin. Nutr. 32, 870–871 (2013).Article

Lassen，K.等人，《胰十二指肠切除术：ERAS建议》。临床。。32870-871（2013）。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Sánchez-Iglesias, J. L. et al. Importance of enhanced recovery after surgery (ERAS) protocol compliance for length of stay in ovarian cancer surgery. Ann. Surg. Oncol. 28, 8979–8986 (2021).Article

Sánchez-Iglesias，J.L.等人。增强术后恢复（ERAS）方案依从性对卵巢癌手术住院时间的重要性。安。外科。Oncol。。文章

PubMed

PubMed

Google Scholar

谷歌学者

Hosoda, K., Niihara, M., Harada, H., Yamashita, K. & Hiki, N. Robot-assisted minimally invasive esophagectomy for esophageal cancer: Meticulous surgery minimizing postoperative complications. Ann. Gastroenterol. Surg. 4, 608–617 (2020).Article

Hosoda，K.，Niihara，M.，Harada，H.，Yamashita，K。＆Hiki，N。机器人辅助食管癌微创食管切除术：细致的手术，最大程度地减少术后并发症。安。肠胃病。Surg.4608-617（2020）。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Shyr, Y. M., Wang, S. E., Chen, S. C., Shyr, B. U. & Shyr, B. S. Robotic pancreaticoduodenectomy for pancreatic head cancer and periampullary lesions. Ann. Gastroenterol. Surg. 5, 589–596 (2021).Article

Shyr，Y.M.，Wang，S.E.，Chen，S.C.，Shyr，B.U。和Shyr，B.S。机器人胰十二指肠切除术治疗胰头癌和壶腹周围病变。安。肠胃病。Surg.5589-596（2021）。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Kornaropoulos, M. et al. Total robotic pancreaticoduodenectomy: A systematic review of the literature. Surg. Endosc. 31, 4382–4392 (2017).Article

Kornaropoulos，M.等。全机器人胰十二指肠切除术：文献的系统综述。外科医师。314382-4392（2017）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Di Franco, G. et al. Robot-assisted pancreatoduodenectomy with the Da Vinci Xi: Can the costs of advanced technology be offset by clinical advantages? A case-matched cost analysis versus open approach. Surg. Endosc. 36, 4417–4428 (2022).Article

Di Franco，G.等人，《达芬奇十一世机器人辅助胰十二指肠切除术：先进技术的成本能否被临床优势所抵消？案例匹配成本分析与开放方法。外科医师。364417-4428（2022）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Liu, R. et al. Single-port (SP) robotic pancreatic surgery using the Da Vinci SP system: A retrospective study on prospectively collected data in a consecutive patient cohort. Int. J. Surg. 104, 106782 (2022).Article

Liu，R.等人。使用达芬奇SP系统的单端口（SP）机器人胰腺手术：对连续患者队列中前瞻性收集数据的回顾性研究。《国际外科杂志》104106782（2022）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Klotz, R. et al. Gastrointestinal complications after pancreatoduodenectomy with epidural vs patient-controlled intravenous analgesia: A randomized clinical trial. JAMA Surg. 155, e200794 (2020).Article

Klotz，R.等人。胰十二指肠切除术后硬膜外与患者自控静脉镇痛的胃肠道并发症：一项随机临床试验。《美国医学会外科杂志》155，e200794（2020）。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Wang, Q. et al. Is routine drainage necessary after pancreaticoduodenectomy?. World J. Gastroenterol. 20, 8110–8118 (2014).Article

Wang，Q。等人。胰十二指肠切除术后是否需要常规引流？。世界J.胃肠病学。208110-8118（2014）。文章

ADS

广告

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Kawaida, H. et al. Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery. World J. Gastroenterol. 25, 3722–3737 (2019).Article

Kawaida，H。等人。胰腺手术后预防术后胰瘘的手术技术和术后管理。世界J.胃肠病学。253722-3737（2019）。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Shi, Y. et al. Short-term outcomes after robot-assisted vs open pancreaticoduodenectomy after the learning curve. JAMA Surg. 155, 389–394 (2020).Article

Shi，Y.等人。学习曲线后机器人辅助与开放式胰十二指肠切除术后的短期结果。《美国医学会外科杂志》155389-394（2020）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Strobel, O. & Büchler, M. W. Drainage after pancreaticoduodenectomy: Controversy revitalized. Ann. Surg. 259, 613–615 (2014).Article

Strobel，O.＆Büchler，M.W。胰十二指肠切除术后的引流：争议再次出现。《安·外科杂志》259613-615（2014）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Fukushima, T. et al. Role of early mobilization on the clinical course of patients who underwent pancreaticoduodenectomy: A retrospective cohort study. Tohoku J. Exp. Med. 254, 287–294 (2021).Article

Fukushima，T.等人，《早期动员对胰十二指肠切除术患者临床过程的作用：一项回顾性队列研究》。《东北J.实验医学》254287-294（2021）。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Download referencesAcknowledgementsWe thank Home for Researchers editorial team (www.home-for-researchers.com) for the language editing service.FundingThis work was funded by the Science and Technology Joint Foundation of Zunyi [HZ (2023) 241].Author informationAuthors and AffiliationsDepartment of Gastrointestinal Surgery, Affiliated Hospital of Zunyi Medical University, No.

下载参考文献致谢我们感谢Home for Researchers编辑团队（www.Home-for-searchers.com）提供的语言编辑服务。资助这项工作由遵义科技联合基金会资助[HZ（2023）241]。作者信息作者和附属机构遵义医科大学附属医院胃肠外科，No。

149, Dalian Road, Huichuan District, Zunyi, 563099, Guizhou Province, ChinaZhenxing Liu, Zhengbiao Li, Jinlong Liang, Tao Zhang, Weiwei Ning & Jiwei WangDepartment of Gastrointestinal Surgery, Guizhou Provincial People’s Hospital, No. 83, Zhongshan East Road, Nanming District, Guiyang, 550499, Guizhou, ChinaHonghong ChenAuthorsZhenxing LiuView author publicationsYou can also search for this author in.

中国贵州省遵义市汇川区大连路149号，邮编563099刘振兴，李正彪，梁金龙，张涛，宁维伟，王吉伟贵州省人民医院胃肠外科，贵阳市南明区中山东路83号，邮编550499，中国陈红红作者刘振兴作者出版物您也可以在中搜索作者。

PubMed Google ScholarHonghong ChenView author publicationsYou can also search for this author in

PubMed谷歌学者陈红红查看作者出版物您也可以在

PubMed Google ScholarZhengbiao LiView author publicationsYou can also search for this author in

PubMed谷歌学者郑彪LiView作者出版物您也可以在

PubMed Google ScholarJinlong LiangView author publicationsYou can also search for this author in

PubMed谷歌学者Jinlong LiangView作者出版物您也可以在

PubMed Google ScholarTao ZhangView author publicationsYou can also search for this author in

PubMed Google ScholarTao ZhangView作者出版物您也可以在

PubMed Google ScholarWeiwei NingView author publicationsYou can also search for this author in

PubMed Google ScholarWeiwei NingView作者出版物您也可以在

PubMed Google ScholarJiwei WangView author publicationsYou can also search for this author in

PubMed谷歌学者Jiwei WangView作者出版物您也可以在

PubMed Google ScholarContributionsZhenxing Liu: Methodology, Writing–original draft, performing the experiments. Honghong Chen: Methodology, Writing–review & editing. Zhengbiao Li: Methodology, performing the experiments, Writing–review & editing. Jinlong Liang: Formal analysis.

PubMed谷歌学术贡献刘振兴：方法论，写作-原稿，进行实验。陈红红：方法论，写作-评论和编辑。李正彪：方法论，实验，写作-评论和编辑。梁金龙：形式分析。

Tao zhang: performing the experiments, and data curation.Weiwei Ning: data curation and Formal analysis. Jiwei Wang: Supervision, Conceptualization, Project administration. All authors have read and approved the final manuscript.Corresponding authorCorrespondence to.

张涛：进行实验和数据管理。魏伟宁：数据管理和形式分析。王继伟：监督，概念化，项目管理。所有作者都阅读并批准了最终手稿。对应作者对应。

Jiwei Wang.Ethics declarations

。道德宣言

Competing interests

相互竞争的利益

The authors declare no competing interests.

作者声明没有利益冲突。

Additional informationPublisher’s noteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Electronic supplementary materialBelow is the link to the electronic supplementary material.Supplementary Material 1Rights and permissions

Additional informationPublisher的noteSpringer Nature在已发布地图和机构隶属关系中的管辖权主张方面保持中立。电子补充材料流是指向电子补充材料的链接。补充材料1权利和许可

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material.

开放获取本文是根据知识共享署名非商业性NoDerivatives 4.0国际许可证授权的，该许可证允许以任何媒介或格式进行任何非商业性使用，共享，分发和复制，只要您对原始作者和来源给予适当的信任，提供知识共享许可证的链接，并指出您是否修改了许可材料。

You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

根据本许可证，您无权共享源自本文或其部分的改编材料。本文中的图像或其他第三方材料包含在文章的知识共享许可证中，除非该材料的信用额度中另有说明。如果材料未包含在文章的知识共享许可中，并且您的预期用途不受法律法规的许可或超出许可用途，则您需要直接获得版权所有者的许可。

To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/..

要查看此许可证的副本，请访问http://creativecommons.org/licenses/by-nc-nd/4.0/..

Reprints and permissionsAbout this articleCite this articleLiu, Z., Chen, H., Li, Z. et al. Clinical efficacy of enhanced recovery surgery in Da Vinci robot-assisted pancreatoduodenectomy.

转载和许可本文引用本文Liu，Z.，Chen，H.，Li，Z。等人。达芬奇机器人辅助胰十二指肠切除术中增强恢复手术的临床疗效。

Sci Rep 14, 21539 (2024). https://doi.org/10.1038/s41598-024-72835-9Download citationReceived: 18 March 2024Accepted: 11 September 2024Published: 15 September 2024DOI: https://doi.org/10.1038/s41598-024-72835-9Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard.

科学报告1421539（2024）。https://doi.org/10.1038/s41598-024-72835-9Download引文收到日期：2024年3月18日接受日期：2024年9月11日发布日期：2024年9月15日OI：https://doi.org/10.1038/s41598-024-72835-9Share本文与您共享以下链接的任何人都可以阅读此内容：获取可共享链接对不起，本文目前没有可共享的链接。复制到剪贴板。

Provided by the Springer Nature SharedIt content-sharing initiative

由Springer Nature SharedIt内容共享计划提供

KeywordsEnhanced recovery after surgeryDa VinciRobotPancreaticoduodenectomyEfficacy

关键词增强术后恢复达·芬奇罗·博特胰十二指肠切除术

CommentsBy submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

评论通过提交评论，您同意遵守我们的条款和社区指南。如果您发现有虐待行为或不符合我们的条款或准则，请将其标记为不合适。